FITLIFE BRANDS, INC. (FTLF) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 3.90M USD | Operating Income (Loss) |
| Revenue | (m) | |
| Cost of products and services | 23.32M USD | Cost of Goods and Services Sold |
| Research and development | (m) | |
| Selling, general and administration | 7.23M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.90M | (m) | $23.32M | (m) | $7.23M | (m) |
| 2026-03-31 | $3.06M | (m) | $15.81M | (m) | $4.96M | (m) |
| 2025-12-31 | $10.06M | (m) | $50.01M | (m) | $14.04M | (m) |
| 2025-09-30 | $10.68M | (m) | $41.84M | (m) | $11.39M | (m) |
| 2025-06-30 | $11.54M | (m) | $36.06M | (m) | $9.93M | (m) |
| 2025-03-31 | $12.70M | (m) | $36.19M | (m) | $9.98M | (m) |
| 2024-12-31 | $13.12M | (m) | $36.39M | (m) | $9.97M | (m) |
| 2024-09-30 | $12.06M | (m) | $35.52M | (m) | $14.44M | (m) |
| 2024-06-30 | $11.35M | (m) | $34.76M | (m) | $13.70M | (m) |
| 2024-03-31 | $10.26M | (m) | $34.20M | (m) | $13.55M | (m) |
| 2023-12-31 | $7.55M | (m) | $31.27M | (m) | $12.16M | (m) |
| 2023-09-30 | $6.47M | (m) | $26.51M | (m) | $10.40M | (m) |
| 2023-06-30 | $5.54M | (m) | $23.38M | (m) | $8.91M | (m) |
| 2023-03-31 | $4.78M | (m) | $18.92M | (m) | $7.12M | (m) |
| 2022-12-31 | $5.70M | (m) | $16.77M | (m) | $6.27M | (m) |
| 2022-09-30 | $6.47M | (m) | $17.71M | (m) | (m) | (m) |
| 2022-06-30 | $6.36M | (m) | $16.40M | (m) | (m) | (m) |
| 2022-03-31 | $6.57M | (m) | $16.79M | (m) | (m) | (m) |
| 2021-12-31 | $6.23M | (m) | $15.41M | (m) | (m) | (m) |
| 2021-09-30 | $6.24M | $26.93M | (m) | (m) | (m) | 23.16% |
| 2021-06-30 | $6.47M | $27.15M | (m) | (m) | (m) | 23.82% |
| 2021-03-31 | $4.43M | $21.75M | (m) | (m) | (m) | 20.35% |
| 2020-12-31 | $4.20M | $21.74M | (m) | (m) | (m) | 19.33% |
| 2020-09-30 | $2.93M | $19.50M | (m) | (m) | (m) | 15.01% |
| 2020-06-30 | $2.14M | $17.89M | (m) | (m) | (m) | 11.98% |
| 2020-03-31 | $2.70M | $19.77M | (m) | (m) | (m) | 13.66% |
| 2019-12-31 | $2.58M | $19.50M | (m) | (m) | (m) | 13.24% |
| 2019-09-30 | $2.30M | $19.31M | (m) | (m) | (m) | 11.93% |
| 2019-06-30 | $1.83M | $18.58M | (m) | (m) | (m) | 9.86% |
| 2019-03-31 | $1.64M | $18.34M | (m) | (m) | (m) | 8.91% |
| 2018-12-31 | $653.00K | $17.08M | (m) | (m) | (m) | 3.82% |
| 2018-09-30 | $-6.79M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $-7.68M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $-8.43M | $16.82M | (m) | (m) | (m) | -50.08% |
| 2017-12-31 | $-8.95M | $17.80M | (m) | (m) | (m) | -50.30% |
| 2017-09-30 | $-2.61M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $-2.49M | $19.65M | (m) | (m) | (m) | -12.66% |
| 2017-03-31 | $-751.98K | $23.02M | (m) | (m) | (m) | -3.27% |
| 2016-12-31 | $472.26K | $25.31M | (m) | (m) | (m) | 1.87% |
| 2016-09-30 | $-26.97K | $24.41M | (m) | (m) | (m) | -0.11% |
| 2016-06-30 | $774.73K | $25.34M | (m) | (m) | (m) | 3.06% |
| 2016-03-31 | $-156.10K | $21.97M | (m) | (m) | (m) | -0.71% |
| 2015-12-31 | $-1.09M | $17.93M | (m) | (m) | (m) | -6.08% |
| 2015-09-30 | $183.34K | $17.29M | (m) | (m) | (m) | 1.06% |
| 2015-06-30 | $380.46K | $16.51M | (m) | (m) | (m) | 2.30% |
| 2015-03-31 | $909.88K | $17.47M | (m) | (m) | (m) | 5.21% |
| 2014-12-31 | $1.85M | $19.96M | (m) | (m) | (m) | 9.28% |
| 2014-09-30 | $2.17M | $21.49M | (m) | (m) | (m) | 10.10% |
| 2014-06-30 | $2.01M | $20.89M | (m) | (m) | (m) | 9.64% |
| 2014-03-31 | $1.71M | $19.96M | (m) | (m) | (m) | 8.57% |
| 2013-12-31 | $1.39M | $19.68M | (m) | (m) | (m) | 7.05% |
| 2013-09-30 | $1.52M | $19.38M | (m) | (m) | (m) | 7.82% |
| 2013-06-30 | $1.50M | $19.08M | (m) | (m) | (m) | 7.87% |
| 2013-03-31 | $1.76M | $19.20M | (m) | (m) | (m) | 9.19% |
| 2012-12-31 | $1.88M | $18.09M | (m) | (m) | (m) | 10.40% |
| 2012-09-30 | $1.37M | $17.44M | (m) | (m) | (m) | 7.84% |
| 2012-06-30 | $1.19M | $16.06M | (m) | (m) | (m) | 7.44% |
| 2012-03-31 | $822.47K | $14.06M | (m) | (m) | (m) | 5.85% |
| 2011-12-31 | $208.66K | $12.09M | (m) | (m) | (m) | 1.73% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-3.10M | $8.15M | (m) | (m) | (m) | -38.06% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |